218 related articles for article (PubMed ID: 1348215)
1. Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells.
Peles E; Bacus SS; Koski RA; Lu HS; Wen D; Ogden SG; Levy RB; Yarden Y
Cell; 1992 Apr; 69(1):205-16. PubMed ID: 1348215
[TBL] [Abstract][Full Text] [Related]
2. Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships.
Peles E; Ben-Levy R; Tzahar E; Liu N; Wen D; Yarden Y
EMBO J; 1993 Mar; 12(3):961-71. PubMed ID: 8096177
[TBL] [Abstract][Full Text] [Related]
3. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.
Marte BM; Jeschke M; Graus-Porta D; Taverna D; Hofer P; Groner B; Yarden Y; Hynes NE
Mol Endocrinol; 1995 Jan; 9(1):14-23. PubMed ID: 7760847
[TBL] [Abstract][Full Text] [Related]
4. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
Bacus SS; Gudkov AV; Zelnick CR; Chin D; Stern R; Stancovski I; Peles E; Ben-Baruch N; Farbstein H; Lupu R
Cancer Res; 1993 Nov; 53(21):5251-61. PubMed ID: 8106145
[TBL] [Abstract][Full Text] [Related]
5. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit.
Wen D; Peles E; Cupples R; Suggs SV; Bacus SS; Luo Y; Trail G; Hu S; Silbiger SM; Levy RB
Cell; 1992 May; 69(3):559-72. PubMed ID: 1349853
[TBL] [Abstract][Full Text] [Related]
6. Neu and its ligands: from an oncogene to neural factors.
Peles E; Yarden Y
Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
8. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
9. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
[TBL] [Abstract][Full Text] [Related]
10. NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells.
Marte BM; Graus-Porta D; Jeschke M; Fabbro D; Hynes NE; Taverna D
Oncogene; 1995 Jan; 10(1):167-75. PubMed ID: 7824269
[TBL] [Abstract][Full Text] [Related]
11. Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy.
Stancovski I; Peles E; Ben Levy R; Lemprecht R; Kelman Z; Goldman-Michael R; Hurwitz E; Bacus S; Sela M; Yarden Y
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):95-103. PubMed ID: 1356018
[TBL] [Abstract][Full Text] [Related]
12. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
13. Biochemical analysis of the ligand for the neu oncogenic receptor.
Yarden Y; Peles E
Biochemistry; 1991 Apr; 30(14):3543-50. PubMed ID: 1672825
[TBL] [Abstract][Full Text] [Related]
14. NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways.
Daly JM; Olayioye MA; Wong AM; Neve R; Lane HA; Maurer FG; Hynes NE
Oncogene; 1999 Jun; 18(23):3440-51. PubMed ID: 10376522
[TBL] [Abstract][Full Text] [Related]
15. Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.
Bacus SS; Stancovski I; Huberman E; Chin D; Hurwitz E; Mills GB; Ullrich A; Sela M; Yarden Y
Cancer Res; 1992 May; 52(9):2580-9. PubMed ID: 1373672
[TBL] [Abstract][Full Text] [Related]
16. A Neu differentiation factor (NDF) domain essential for proliferation and alterations in morphology of colonic epithelial cells in vitro.
Whoriskey JS; Pekar SK; Elliott GS; Hara S; Liu N; Lenz DM; Zamborelli T; Mayer JP; Tarpley JE; Lacey DL; Ratzkin B; Yoshinaga SK
Growth Factors; 1998; 15(4):307-21. PubMed ID: 9714914
[TBL] [Abstract][Full Text] [Related]
17. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
Muthuswamy SK; Muller WJ
Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional aspects of the multiplicity of Neu differentiation factors.
Wen D; Suggs SV; Karunagaran D; Liu N; Cupples RL; Luo Y; Janssen AM; Ben-Baruch N; Trollinger DB; Jacobsen VL
Mol Cell Biol; 1994 Mar; 14(3):1909-19. PubMed ID: 7509448
[TBL] [Abstract][Full Text] [Related]
19. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
Ethier SP; Kokeny KE; Ridings JW; Dilts CA
Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
[TBL] [Abstract][Full Text] [Related]
20. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.
Beerli RR; Graus-Porta D; Woods-Cook K; Chen X; Yarden Y; Hynes NE
Mol Cell Biol; 1995 Dec; 15(12):6496-505. PubMed ID: 8524214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
